Back to Top

Aims & Scope


Launching in 2020

PHAGE: Therapy, Applications, and Research is the only peer-reviewed journal dedicated to fundamental bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production. Under the distinct leadership of Editor-in-Chief Martha Clokie, PhD, University of Leicester, United Kingdom, the Journal showcases groundbreaking research, reviews, commentaries, opinion pieces, profiles, and perspectives dedicated to defining the roles of phages in all facets of microbiology and microbial ecology and exploring their potential to manipulate bacterial communities and treat infection.

PHAGE is the critical resource for molecular biologists, microbiologists, bacteriologists, bioengineers, immunologists, clinicians, and translational biologists, and aims to unify this evolving cluster of innovative researchers, industry leaders, clinicians, and policy makers. The Journal also advances knowledge and development in this re-emerging area of research and opens doors for new ideas and funding opportunities for researchers and clinicians in the field. 

PHAGE: Therapy, Applications, and Research coverage will include:

  • Life cycle of phages
  • Capsid structure and morphology
  • Genome organization and content
  • Phage transcriptional takeover and regulation
  • Roles of phages in natural ecosystems
  • Impacts of phages on bacterial/eukaryotic physiology
  • Immune cell modulation by phages
  • Multidrug and antibiotic resistance
  • Regulation of gut microbiota and GI infections
  • Regulation of lung/skin/bladder/blood/bone and other infections
  • Application of phages post-surgery
  • Genetic engineering of phages
  • Roles of synthetic phages to manipulate inflammation and cancer
  • Impact and exploitation of CRISPR-Cas systems
  • Phages as vectors for gene delivery
  • Vaccine development
  • Phage based diagnostics
  • Phage proteins and enzymes
  • Bacteriophage lysins
  • Phage therapy in plants
  • Phage therapy in aquaculture and fisheries
  • Phages and food production and safety
  • Nanotechnology and materials science
  • Drug, gene, and antibody delivery
  • Novel model systems to study phage behavior
  • Clinical and animal trials
  • Phage therapy ethical and regulatory challenges
  • Phage therapy policy

PHAGE is under the editorial leadership of Martha Clokie, PhD, University of Leicester, and other leading investigators.

Audience: Biochemists, biophysicists, microbiologists, molecular biologists, bacteriologists, bioengineers, translational biologists, immunologists, food microbiologists, biomedical and biomaterials engineers, marine biologists, clinicians, veterinarians, and policymakers, among others.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.